Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-005899
Filing Date
2025-02-27
Accepted
2025-02-27 18:32:38
Documents
1
Period of Report
2025-02-25

Document Format Files

Seq Description Document Type Size
1 form4-02272025_110233.html 4  
1 form4-02272025_110233.xml 4 13041
  Complete submission text file 0001415889-25-005899.txt   14653
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121
Business Address
LaBarre Michael J. (Reporting) CIK: 0001507174 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 25681546